Johnson & Johnson’s set to lose patent on key TB drug in July{br} https://ift.tt/Odiz62s

In one of the most-watched patent cases in recent times, the Indian Patent Office on Thursday rejected American giant Johnson & Johnson’s (J&J) attempt to extend its monopoly on life-saving TB drug bedaquiline beyond July this year. The development made public coincidentally on the eve of the World TB Day — will improve access to the core drug, Bedaquiline, which is part of the WHO recommended all-oral TB regimen.

from Times of India https://ift.tt/QEPMZBf

Comments

Post a Comment

Popular posts from this blog

'A hard goodbye with...': Pathirana to CSK and Dhoni{br} https://ift.tt/vpqjikg

Chennai Super Kings' pacer Matheesha Pathirana's participation in the current IPL season seems to be over as he returns to Sri Lanka to recuperate from a hamstring injury. The right-arm fast bowler appeared in six matches this IPL season, claiming 13 wickets with an economy rate of 7.68. Pathirana's final game for CSK was their 78-run win against Sunrisers Hyderabad, where he bowled two overs and took the wickets of Aiden Markram and Heinrich Klaasen. from Times of India https://ift.tt/YwB9gnD
Read more